Single-dose Safety Study of APD916 in Healthy Volunteers

Clinical trial NCT01093508 · COMPLETED

Trial details

NCT number: NCT01093508
Sponsor: Arena Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Narcolepsy With or Without Cataplexy

Start date: 2010-03-01
Primary completion: 2010-04-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.